Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Pancreatic Cancer by AJCC v6 and v7 Stage	NCIT_C134902	[A term that refers to the staging of exocrine and endocrine pancreatic cancer including well-differentiated neuroendocrine tumors according to the American Joint Committee on Cancer, 6th and 7th editions.]
Stage III Pancreatic Cancer AJCC v6 and v7	NCIT_C7787	[Stage III includes: T4, Any N, M0. T4: Tumor involves the celiac axis or the superior mesenteric artery. M0: No distant metastasis. (AJCC 6th and 7th Eds.)]
Localized Osteosarcoma	NCIT_C7780	[A non-disseminated osteosarcoma.]
Metastatic Osteosarcoma	NCIT_C7781	[An osteosarcoma which has spread to another anatomical site.]
Stage IIIB Breast Cancer AJCC v7	NCIT_C7782	[Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.)]
Recurrent Lung Non-Small Cell Carcinoma	NCIT_C7783	[The re-emergence of non-small cell lung carcinoma after a period of remission.]
Recurrent Lung Carcinoma	NCIT_C8953	[Lung carcinoma that has re-emerged after a period of remission.]
Lung Non-Small Cell Carcinoma	NCIT_C2926	[A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.]
Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma	NCIT_C7799
Stage III	NCIT_C27970	[Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.]
Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma	NCIT_C7795
Stage I	NCIT_C27966	[Invasive cancer confined to the original anatomic site of growth without lymph node involvement.]
Stage I Mycosis Fungoides AJCC v7	NCIT_C7796	[Stage I includes: IA (T1, N0, M0, B0-1); IB (T2, N0, M0, B0-1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.)]
Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma	NCIT_C7797
Stage II	NCIT_C28054	[Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.]
Stage II Mycosis Fungoides AJCC v7	NCIT_C7798	[Stage II includes: IIA (T1-2, N1-2, M0, B0-1); IIB (T3, N0-2, M0, B0-1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.)]
Stage II Rectal Cancer AJCC v6	NCIT_C7791	[Stage II includes IIA (T3, N0, M0) and IIB (T4, N0, M0). T3: Tumor invades through the muscularis propria into the subserosa, or into nonperitonealized pericolic or perirectal tissues. T4: Tumor directly invades other organs or structures, and/or perforates the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003]
Stage II Colorectal Cancer AJCC v6	NCIT_C8514	[Stage Group II is subdivided into IIA and IIB on the basis of whether the primary tumor is T3 or T4, respectively. T3: Tumor invades through the muscularis propria into the subserosa, or into non-peritonealized pericolic or perirectal tissues. T4: Tumor directly invades other organs or structures, and/or perforates visceral peritoneum. (AJCC 6th ed.) - 2003]
Rectal Cancer by AJCC v6 Stage	NCIT_C90508	[A term that refers to the staging of rectal carcinoma according to the American Joint Committee on Cancer, 6th edition.]
Stage III Rectal Cancer AJCC v6	NCIT_C7792	[Stage III includes: IIIA (T1-T2, N0, M0); IIIB (T3-T4, N1, M0); IIIC (Any T, N2, M0). N1: Metastasis in 1 to 3 regional lymph nodes. N2: Metastasis in 4 or more regional lymph nodes. (AJCC 6th ed.) - 2003]